Target intelligence / Profile preview

RNA, U6 small nuclear 28, pseudogene (RNU6-28P)

Target
RNU6-28P
Molecular classification
Pseudogene (non-coding RNA analog), Other
01

Overview

RNU6-28P (RNA, U6 small nuclear 28, pseudogene) is a genomic sequence classified as a pseudogene, derived from duplication or retrotransposition of the U6 small nuclear RNA gene[1][5]. It does not produce a functional RNA or protein and is not involved in splicing or cellular signaling. Pseudogenes such as RNU6-28P serve primarily as genomic fossils without active cellular or disease roles. The functional ancestral U6 snRNA is deeply conserved among eukaryotes and is indispensable for catalyzing pre-mRNA splicing in the nucleus[5][3]; however, RNU6-28P lacks the appropriate regulatory structures and is non-functional. Its presence reflects evolutionary duplications, frequently observed in the non-coding RNA gene families of vertebrate genomes[5]. There are no known disease associations, therapeutic utilities, or biomarker roles for RNU6-28P. If you are seeking information on active therapeutic targets, this pseudogene should be excluded from target or biomarker lists, and attention should be focused instead on functional U6 snRNA or other small nuclear RNAs with proven biological activity[2][3][5].

Other names
RNU6-28RNU6-28PRNA, U6 small nuclear 28, pseudogeneU6-28 pseudogene
02

Mechanism of action

Not applicable; pseudogenes do not encode active products. Parent U6 snRNA is involved in RNA splicing; pseudogene has no mechanism or drug targeting.

03

Biological functions

None established; pseudogenes are generally non-functional.By analogy, the parental U6 small nuclear RNA is involved in spliceosome assembly and pre-mRNA splicing.RNU6-28P does not participate in biological processes directly.
04

Disease associations

None proven for RNU6-28P.The parent functional U6 snRNA is sometimes discussed in cancer, chiefly as a normalization control in gene expression studies, and shows instability in disease states.RNU6-28P has not been implicated as a biomarker, regulator, or target in any disease.
05

Safety considerations

None known or anticipated, as the pseudogene is biologically inactive.
06

Interacting drugs

None. No drugs are known or predicted to interact with this pseudogene.
07

Biomarkers

None.The parent functional U6 snRNA (not RNU6-28P) has sometimes been used as a reference gene in qPCR biomarker studies, but shows tissue and disease-specific instability.RNU6-28P is not used as a biomarker.

Beyond the preview

Go deeper on RNA, U6 small nuclear 28, pseudogene (RNU6-28P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 28, pseudogene (RNU6-28P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call